Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemiaMaurizio Mangolini, Ingo Ringshausen|Nature Communications|2018Cited by 76
Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistanceEugene Park, Ingo Ringshausen|Science Translational Medicine|2020Cited by 35
Matching-adjusted indirect comparisons of safety and efficacy of acalabrutinib versus other targeted therapies in patients with treatment-naïve chronic lymphocytic leukemiaMatthew S. Davids, Ingo Ringshausen, Claire Telford et al.|Leukemia & lymphoma/Leukemia and lymphoma|2021Cited by 16
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLLLavinia Arseni, Martina Seiffert, Gianluca Sigismondo et al.|Nature Communications|2025Cited by 5
Strong constitutive NF-κB signaling in B cells drives SLL/CLL-like lymphomagenesis and overcomes microenvironmental dependenciesValeria Soberón, Marc Schmidt-Supprian, Thomas J. O’Neill et al.|Leukemia|2026Cited by 0